Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/34804
Title: Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis
Authors: Lin, Chunqing
Slama, Jiri
Gonzalez, Paula
Goodman, Marc T.
Xia, Ningshao
Kreimer, Aimée R
Wu, Ting
Hessol, Nancy A
Shvetsov, Yurii
Ortiz, Ana P
Grinsztejn, Beatriz
Moscicki, Anna-Barbara
Heard, Isabelle
Del Refugio González Losa, María
Kojic, Erna M
Schim van der Loeff, Maarten F
Wei, Feixue
Longatto-Filho, Adhemar
Mbulawa, Zizipho A
Palefsky, Joel M
Sohn, Annette H
Hernandez, Brenda Y
Robison, Katina
Simpson, Steve
Conley, Lois J
de Pokomandy, Alexandra
van der Sande, Marianne A B
Dube Mandishora, Racheal S
Volpini, Lays P B
Pierangeli, Alessandra
Romero, Byron
Wilkin, Timothy
Franceschi, Silvia
Hidalgo-Tenorio, Carmen
Ramautarsing, Reshmie A
Park, Ina U
Tso, Fernanda K
Godbole, Sheela
D'Hauwers, Kathleen W M
Sehnal, Borek
Menezes, Lynette J
Heráclio, Sandra A
Clifford, Gary M
Affilliation: International Agency for Research on Cancer, Lyon, France; National Cancer Center, National Clinical Research Center for Cancer, and Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Department of Gynecology and Obstetrics, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica.
Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA.
State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, Fujian, China.
National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, Fujian, China.
University of California, San Francisco, CA, USA.
University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
University of Puerto Rico Comprehensive Cancer Center, Department of Biostatistics and Epidemiology, Graduate School of Public Health, UPR, San Juan, Puerto Rico
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS.Rio de Janeiro, RJ, Brasil.
David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Department of Endocrinology and Reproductive Medicine, IE3M, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique, Hôpitaux de Paris, Paris, France.
Dr Hideyo Noguchy Center of Regional Investigations, Autonomous University of Yucatán, Mérida, Yucatán, México.
Mount Sinai West and St Luke's Hospitals, New York, NY, USA.
Department of Infectious Diseases, Infectious Diseases Research & Prevention, GGD Amsterdam, Netherlands.
State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, Fujian, China.
Research Institute of Life and Health Sciences, School of Medicine, University of Minho, Braga, Portugal; 3B's (Biomaterials, Biodegradables and Biomimetics) Research Group, Portugal Government Associate Laboratory, Braga, Portugal; Laboratory of Medical Investigation 14, Department of Pathology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil; Teaching and Research Institute, Molecular Oncology Research Center, Barretos Cancer Hospital-Pio XII Foundation, Barretos, Brazil.
Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Department of Pathology, Division of Medical Virology, University of Cape Town, Cape Town, South Africa; Centre for HIV and STIs, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa; South African Medical Research Council Gynaecological Cancer Research Centre, University of Cape Town, Cape Town, South Africa
University of California, San Francisco, CA, USA.
TREAT Asia/amfAR-Foundation for AIDS Research, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
Obstetrics & Gynecology and Medicine, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
Division of HIV/AIDS Prevention, Epidemiology Research Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Chronic Viral Illness Service, McGill University Health Centre and Department of Family Medicine, McGill University, Montreal, QC, Canada.
Public Health Epidemiology, Head Department Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Department of Medical Microbiology, University of Zimbabwe College of Health Sciences, Parirenyatwa Hospital premises, Harare, Zimbabwe.
Universidade Federal do Espírito Santo. Centro de Ciências da Saúde. Espírito Santo, Vitória, Brasil.
Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Weill Cornell Medicine, New York, NY, USA.
Aviano Cancer Center, Aviano, Italy.
Infectious Diseases Service, University Hospital Virgen de las Nieves, Granada, Spain.
Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
Department of Family and Community Medicine, University of California San Francisco School of Medicine, San Francisco, CA, USA.
Department of Gynecology of the Federal University of São Paulo, São Paulo, Brazil.
Division of Epidemiology and Biostatistics, ICMR-National AIDS Research Institute, Indian Council of Medical Research, Pune, India
Radboud University Nijmegen, Medical Centre, Department of Urology, Nijmegen, Netherlands.
Department of Gynecology and Obstetrics, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
Division of Infectious Disease, University of South Florida, Tampa, FL, USA.
Women's Healthcare Center, Instituto de Medicina Integral Professor Fernando Figueira, Recife, PE, Brazil; Cytopathology Division, Public Health Laboratory of the State of Pernambuco, Recife, PE, Brazil.
International Agency for Research on Cancer, Lyon, France.
Abstract: Cervical cancer screening might contribute to the prevention of anal cancer in women. We aimed to investigate if routine cervical cancer screening results-namely high-risk human papillomavirus (HPV) infection and cytohistopathology-predict anal HPV16 infection, anal high-grade squamous intraepithelial lesions (HSIL) and, hence, anal cancer.
Keywords: Cervical cancer
HPV
HSIL
HIV
Issue Date: 2019
Publisher: Elsevier
Citation: LIN, Chunqing et al. Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis. The Lancet. Infectious diseases, v. 19, n.8, p. 880-891, 2019
DOI: 10.1016/S1473-3099(19)30164-1
ISSN: 1473-3099
Copyright: restricted access
Appears in Collections:INI - Artigos de Periódicos

Files in This Item:
File Description SizeFormat 
Cervical determinants_Beatriz_Grinsztejn_INI_Lapclin-AIDS_2019.pdf381.58 kBAdobe PDF    Request a copy



FacebookTwitterDeliciousLinkedInGoogle BookmarksBibTex Format mendeley Endnote DiggMySpace

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.